AYTU BIOPHARMA, INC. (AYTU) Free cash flow 2017–2026
AYTU BIOPHARMA, INC. (AYTU) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$3.3MFY2026 · since FY2017: -$13.9M → $3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.3M | +250.2% |
| FY2025 | -$2.2M | -26.1% |
| FY2024 | -$1.7M | — |
| FY2022 | -$28.8M | -1.8% |
| FY2021 | -$28.3M | +0.2% |
| FY2020 | -$28.4M | -104.3% |
| FY2019 | -$13.9M | +13.3% |
| FY2018 | -$16.0M | -14.9% |
| FY2017 | -$13.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AYTU financial trends
AYTU RevenueAYTU Net incomeAYTU Net marginAYTU Gross profitAYTU Gross marginAYTU Operating incomeAYTU Operating marginAYTU Operating cash flowAYTU Capital expendituresAYTU Return on equityAYTU Stock buybacksAYTU Dividends paidAYTU Total assetsAYTU Total liabilitiesAYTU Shareholders’ equityAYTU overview →